Rtw Investments »

Crinetics Pharmaceuticals In shares owned by Rtw Investments

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $36M 872k 41.65
2025-06-30 $13M 467k 28.76

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Argenx Se Sponsored Adr (ARGX)
Avidity Biosciences Ord (RNA)
Ptc Therapeutics I (PTCT)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
Akero Therapeutics (AKRO)
Uniqure Nv SHS (QURE)
Penumbra (PEN)
RadNet (RDNT)
Merus N V (MRUS)
Tarsus Pharmaceuticals (TARS)
Stryker Corporation (SYK)
Immunocore Hldgs Ads (IMCR)

View all positions for Rtw Investments

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Driehaus Capital Management
Farallon Capital Management
EcoR1 Capital
Henderson Group
Paradigm Biocapital Advisors
Geode Capital Management
State Street Corporation
Jennison Associates
Point72 Asset Management
Siren
Novo A/S

View all funds holding Crinetics Pharmaceuticals In